Intrathecal thyroid autoantibody synthesis in a subgroup of patients with schizophreniform syndromes

Dominique Endres*, Rick Dersch, Benedikt Hochstuhl, Bernd Fiebich, Tilman Hottenrott, Evgeniy Perlov, Simon Maier, Benjamin Berger, Annette Baumgartner, Nils Venhoff, Oliver Stich, Ludger Tebartz van Elst

*Korrespondierende/r Autor/-in für diese Arbeit
16 Zitate (Scopus)

Abstract

Schizophreniform syndromes in combination with autoimmune thyroiditis and increased serum thyroid antibodies lead healthcare practitioners to consider a diagnosis of Hashimoto’s encephalopathy. To detect specific biomarkers, the authors analyzed whether intrathecal antithyroid antibody synthesis occurred in a subgroup of schizophreniform patients. In doing so, the authors analyzed thyroid antibodies in paired cerebrospinal fluid and serum samples from 100 schizophreniform patients. Increased antibody indices (AIs) for antithyroid peroxidase or antithyroglobulin autoantibodies in 13 schizophreniform patients were found. AIs were increased in 68% of the seropositive patients. These findings support the hypothesis that autoimmune processes may contribute to the pathophysiology in these patients.

OriginalspracheEnglisch
ZeitschriftJournal of Neuropsychiatry and Clinical Neurosciences
Jahrgang29
Ausgabenummer4
Seiten (von - bis)365-374
Seitenumfang10
ISSN0895-0172
DOIs
PublikationsstatusVeröffentlicht - 01.09.2017

Fördermittel

Supported by the Department for Psychiatry and Psychotherapy of the University Medical Center Freiburg. BF has received grant and research support from Bayer Vital GmbH. TH has received travel grants from Bayer Vital GmbH and Novartis. BB has received travel grants from Bayer Vital GmbH, Ipsen Pharma GmbH, and Genzyme. AB has received consulting and lecture fees, as well as grant and research support, from Bayer Vital GmbH, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis, and Teva. NV has served on advisory boards of, has participated in lectures for, and/or received research or travel grants from AbbVie, GSK, Janssen-Cilag, Medac, Novartis, and Roche. OS has received consulting and lecture fees and grant and research support from Bayer Vital GmbH, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, and Teva. LTvE has served on advisory boards of, has participated in lectures for, and/or received travel grants from Cyberonics, Eli Lilly, GlaxoSmithKline, Janssen, Janssen-Cilag, Novartis, Servier, Shire, and UCB. All other authors report no financial relationships with commercial interests.

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Gesundheitswissenschaften: Logopädie, Ergotherapie, Physiotherapie und Hebammenwissenschaft

DFG-Fachsystematik

  • 2.22-22 Klinische Immunologie und Allergologie
  • 2.23-09 Biologische Psychiatrie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Intrathecal thyroid autoantibody synthesis in a subgroup of patients with schizophreniform syndromes“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren